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Summry Both cutaneous and uveal melanoma undergo haematogenous dissemination. Detection of
tyrosinase mRNA by reverse transcription-polymerase chain reaction (RT-PCR) has been described as an
extremely sensitive way of detecting circulating viable melanoma cells in the penrpheral venous blood, and this
technique may be of value in the early detection of dissemination. Also, it has been suggested that surgical
manipulation of the eye, such as occurs during enucleation, can provoke uveal melanoma dissemination. The
purpose of this study was to evaluate whether tyrosinase mRNA is detectable in the peripheral blood of
patients with uveal and cutaneous melanoma and in patients with uveal melanoma undergoing surgical
procedures on the eye harbouring the tumour. Venous blood samples from 36 patients diagnosed as having
active uveal melanoma and from six patients with advanced metastatic cutaneous melanoma were analysed. In
addition, blood samples were spiked with known numbers of cells from three cell lines and four primary uveal
melanoma cultures. The reported sensitivity of the technique was confirmed, with an ability to detect down to
one cell per ml of blood. All 51 blood samples from the 36 patients with uveal melanoma were negative, and
this included 20 perioperative blood samples. The test was also negative for the six patients with advanced
cutaneous melanoma. There were two positives among 31 control samples analysed. This study demonstrates
that there are far fewer circulating viable melanocytes than has been previously supposed in patients with
melanoma and that the RT-PCR is of no clinical value in detecting metastatic melanoma disease. There was
no evidence for surgery causing a bolus of melanoma cells to enter the peripheral circulation.
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There have been many attempts to detect circulating cells
from solid malignant tumours in peripheral blood. Many
malignant tumours spread via the bloodstream and, while the
number of such cells thought to be present is relatively small,
it is these cells that will be a major factor in determining the
patients' final outcome. The detection of such cells is poten-
tially important, both clinically, as presumably their presence
would be an adverse prognostic factor, and scientifically, as it
would allow the isolation, and subsequent study, of such cells
by fractionation procedures.
Early attempts used microscopy to examine the cells
retained on 'sieves' after filtration of blood samples (Gold-
blatt and Nadel, 1965; McGrew, 1965; Seal, 1964; Stanford,
1971). However, these techniques were unreliable owing to
the difficulties of differentiating tumour cells from other
retained cell types, and these techniques have now been
abandoned. An immunocytochemical technique has been des-
cribed for the detection of micrometastases for breast car-
cinoma in bone marrow aspirates (Redding et al., 1983) and
for neuroblastoma cells in penpheral blood (Moss and
Sanders, 1990). This technique depends upon the availability
of specific antibodies to tumour-specific cell-surface antigens
and the best sensitivity described for this technique is 2/
100 000 mononuclear cells, which is about 140 cells per ml of
peripheral blood.
More recently Smith et al. (1991) described a technique for
melanoma cells capable of detecting a single cell in 2 ml of
blood. This is very close to the theoretical maximum sen-
sitivity of one cell per blood sample, with the potential
sensitivity only limited by what can be considered to be a
reasonable volume for a blood sample. The technique des-
cribed by the above group and tested here is based on the
almost unlimited amplification potential of the polymerase
chain reaction (PCR), which is capable of detecting a single
molecule of a target cDNA sequence in a reaction mix. The
target, in this study, is the tyrosinase mRNA, as tyrosinase
expression is not found in normal peripheral blood cells and
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its presence is taken as a marker for circulating melanocytes.
Tyrosinase cDNA is synthesised by reverse transcription
(RT), and a nested PCR specific for the tyrosinase cDNA is
the detection system. Smith et al. found evidence of cir-
culating melanoma cells in four out of seven patients with
cutaneous melanoma and in none out of eight controls and a
pilot study, performed by us using their technique, on six
patients with uveal melanoma also showed potential (Tobal
et al., 1993).
The technique showed particular promise for uveal
melanomas, which is the commonest primary intraocular
malignancy. Cutaneous melanomas initially metastasise via
the lymphatics, but the uveal tract of the eye is unusual in
that it does not have lymphatics and metastasis to regional
lymph nodes is very unusual. Instead, spread is
haematogenous, with approximately 40% developing
evidence of metastatic disease by 10 years (McLean et al.,
1977, 1982; Shammas and Blodi, 1977) despite the fact that
only 1% ofpatients show evidence of metastases at presenta-
tion (Char, 1978). Fraunfelder et al. (1977) suggested that
surgery could provoke metastatic spread, and this was fol-
lowed by the proposal that two-thirds of metastatic disease is
attributable to surgical manipulation of the globe during
enucleation for uveal melanoma (Zimmerman et al., 1978;
7immerman and McLean, 1979; McLean et al., 1982).
This study had four aims. We wished to assess the sen-
sitivity of RT-PCR for tyrosinase mRNA in detecting cir-
culating cells, to determine what proportion ofpatients tested
positive, whether a positive test implied a poor prognosis and
whether surgical manipulation of an eye containing uveal
melanoma resulted in dissemination of tumour cells into the
systemic circulation.
Materials ad methods
Patients andsanple collection
Thirty-six patients with active uveal melanoma were rec-
ruited. The study followed the tenets of the Declaration of
Helsinki and informed consent was obtained after the natureAEAFssetf
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of the study was explained. The study received formal app-
roval from the Moorfields Ethical Comnittee. Blood samples
from six patients with advanced metastatic cutaneous
melanoma were also studied.
The ocular diagnosis was made by an experienced cinician
on the basis ofbinocular indirect ophthlmoscopy and ocular
ultrasonography. The diagnoses of cutaneous melanoma, in
the patients recruited, were confirmed by biopsy.
Two or more 3.2 ml samples of peripheral venous blood
were collected from veins in the antecubital fossa into tubes
containing EDTA. The blood was stored at 4C and pro-
cessed within 2-4 h. The blood from the patients with
advanced cutaneous melanoma was coLected at a separate
location and stored at -70-C for 4-12 weeks before process-
ing.
Preparation ofRNA and cDNA
The samples underwent centrifugtion at 1000 g for 10min,
and the plasma was discarded. Total cellular RNA was ext-
racted by the one-step guanidium thiocyanate method
(Chomczynski and Sacchi, 1987). The yield from 3.2 ml of
blood was 40-80 ag as determined by optical density
readings, and quality was confirmed by running an RNA gel.
A 1.5 ml volume of the one-step extrction mix (one-fifth of
the total volume) was processed, the RNA was precipitated
with isopropanol at -20-C overnight and washed with ice-
cold 70% ethanol and the final pellet was redissolved in 14 id
of water. Reverse tanscription was performed on 10.4in of
this (6-12Mg of total RNA) in a 15 i reaction mix contain-
ing 1 1ig of oligo-dTt2-l8 and 1 mg of random 10-mers as
primers, recombinant RNAsin (Promega N2512; Promega,
Chilworth Research Centre, Southampton, UK), 1 mmol 1'
of each dNTP (Stratagene 200415; Stratagene, Cambridge,
UK) and 20 units of AMV reverse transcriptase (Northumb-
ria Biolab 20604) in 1 x RT buffer (50 mmol 1- potassium
chloride, 20mmol I-1 Tris pH 8.4, 2.5 mmol 1I magnesum
chloride and 0.lg/l bovine serum albuin). The RNA and
buffer were heated to 65C for 5 min and cooled on ice for
3 mm before the rest of the reaction mix was added. Then
the mix was allowed to stand for 12 min at room
temperature, to allow primer annealing, before incubating at
42-C for 90mi.
Polymerase chain reaction
One-third of the RT reaction product (5sal) was diluted to
50 1 containing final concentrations of 1 x PCR buffer with
additional magnesum chloride to give a fimal concentration
of 2.0mmoll-', 200p1moll'- of each dNTP, 2.5U of Taq
DNA polymerase (Stratagene 600132) and 50pmol of each
primer HTYR1 (5'-TTGGCAGATTGTCTGTAGCC-3') and
HTYR2 (5'-AGGCATTGTGCATGCTG CTT-3). A com-
mon reaction mix was made and aliquoted into separate
0.5 ml clear Eppendorf tubes, with the negative controls
being the last aliquots taken. Tbe samples were overlaid with
oil and laid on their sides and iradiated for 10min with
254 nm wavelength ultraviolet light at 700;LWcmW (uwg
Amplrad, Genetic Research Intrumentation, Felsked, Essex,
UK) in order to nick any contaminating DNA. The template
was then added. The first round ofPCR was then caried out
(96C for 3 min then 35 cycles of 60-C for 45 s, 72-C for 30 s
and 94-C for 60 s). Five microlitres of each sample was then
reamplified, with the only difference in the reaction mix being
the magnesium chloride concentration, which was adjusted to
2.25 mmol1'-l, and the primers used were HTYR3 (5'-
GTCIl TATGCAATGGAACGC-3) and HTYR4 (5'-
GCTATCCCAGTAAGTGG ACT-31. The first-and second-
round primers have been described previously (Smith et al.,
1991; Tobal et al., 1993) and are specific for human
tyrosinase cDNA. The second-round PCR was then per-
formed (96%C for 3 min then 25 cycles of 60'C for 45 s, 72-C
for 30 s and 94-C for 60 s). The first round gives a 284 bp
band and the second round a 207 bp produt. These were
then visualised by running on a flat-bed, sublmrged 2%
agarose gel stained with 0.5Mgml-' ethidium bromide and
the gel viewed and photographed under ultraviolet light at
307 nm.
RT-PCR specific for P-actin was performed in order to
check blood RNA integrity and cDNA synthesis. A 2Ml
volume of the RT mix was diluted in 25 il of PCR mix
(200pM of each dNTP, 1.25 U of Taq, 1.75 mmol I'
magnesium chloride and 1 x PCR buffer) containing
12.5 pmol of each of the primers 5'-GAGCACAGAGCCTC-
GCCTTTGC-3' and 5'-GGATCITCATGAGGTAGTCA-
GTCAGG-3' (which are specific for -actin cDNA) followed
by amplificaton (96C for 3 min then 30 cycles of 60 C for
45 s, 72C for 30 s and 94C for 60 s) to give a 620bp
product.
The positive control for the PCR was the plasmid PmeL34
(Kwon et al., 1987), which contais the tyrosinase cDNA
sequence and which had been linearised by digestion with
EcoRI.
Each PCR run contained at least three negative controls,
including a pipette negative control (after adding the positive
control, the tip of the pipette was changed and a dummy
pipetting action performed in a negative control). In addition
to the PCR negative controls, at least one RNA extrac-
tion RT-PCR and one RT-PCR negative control were pro-
cessed with each run.
Several general measures were employed to reduce the risk
of false positives from either plasmid or carry-over con-
tamination from previously amplified product. The RNA
extraction was performed in a separate room in a class 2
containment hood using new pipettes with aerosol-resistant
pipette tips which had never been used for DNA work. The
RT and PCR set-up steps were also done in a separate room
in a class 2 containmnt hood with the operator gloved and
gowned with the gowns and clothing washed between
experiments and the pipettes iradiated with UVB in the
Ampirad for 1 h (30min each side). The template from the
RT step and the plasmid positive controls were added to the
room in a third reaction mix in a third room in a third class
2 containment hood and the PCR machine was kept in a
fourth room with the gel ekctrophoretic tankrs. After the gels
had been run and photographed, the gels, samples and runn-
ing buffer were all discarded into an autoclave bag and
autoclaved and the gel tanks and all work surfaces leaned
between experiments. The RT and PCR set-ups and the
addition of template were performed with PCR-positive dis-
placement pipettes with disposable plungers as well as tips.
All reagents were aliquoted into single-use aliquots and
residual reagent from each aliquot was discarded. The first-
round primers were purchased pre-aliquoted (courtesy of R
and D systems, Abingdon, Oxon, UK) in DEPC-treated
water.
Tissue culture
The sensitivity of the assay was using samples handl-
ed identically to the dinical sampls but spiked with known
numbers ofcells derived from the cell lines VUP, SK-mel-19,
SK-mel-23 and four primary uveal melanoma cell cultures.
The primary uveal melanoma cell cultures were established
from fresh uveal melanoma tissue taken from surgical
enucleation specmens and were maintained in Dulbeo's
modified Eagl medium containing peniciin (100unitsml-'),
streptomycin (l00Mgml-'), gentamicin (50gml-'), fim-
gizone (0.25Mgml-') and glutami (2 mmol 1'-) and supp-
lemented with 10% (v/v) fetal calf serum (all Gibco Life
Technologies, Paisley, UK). Briefly, the tissue was
mchanically dipd with salpels, centrfuged at 1000
r.p.m. for 8 min and the resultant pellet resspned in
growth medium and seeded into tissue culture flasks. Small
pieces of tissue remaining after centrifugation were anchored
to the bottom of the flasks with glss coverslips. This proce-
dure resulted in the attachment and growth of cells from
both suspensions and tissue explants. The majority of the
cells in these cultures were melanotic cells as determined by
inspection and showed positive immunoytohemical stainingDdectwio mdocyles by PCR
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for HMB45. The cells were removed from the culture flasks
by trypsinisation and the viable cells counted, by trypan blue
exclusion on a haemocytometer, before being used.
Results
The major technical problem was false positives from carry-
over contamination and was solved as detailed in the
Materials and methods section.
Assessment ofPCR sensitivity
PCR sensitivity was assessed using the linearised plasmid
Pmel34. The amount of DNA required to be visible as a
band on an ethidium bromide-stained gel is 5-50 ng. Allow-
ing for the 10-fold dilution at the nested step and the fact
that only one-fifth of the final reaction product is run on the
gel, an amplification of 10'3 is required, which corresponds to
44 doublings. Thirty cycles of the first round were able to
achieve 108 fold amplification close to its maximum
theoretical efficiency, as did the second round, giving a com-
bined amplification of 1016. The sensitivity of the nested PCR
was determined by limiting dilution. A concentration of
lOpgml-' of the cut plasmid was serially diluted with high-
performance liquid chromatography (HPLC)-purified water
to generate three concentrations of positive controls at what
was calculated to be about 30, 3 and 0.3 copies g1-', and 2 gl
of each was used as the controls. Using the Poisson distribu-
tion, a more accurate estimate of the number of copies
present can be made from the observed proportions of
negative reactions. The observed negative rates were 0/18,
6/27 and 10/12 respectively for the three positive control
dilutions, suggesting that the mean amount of template
added was >3.6, 1.5 and 0.18 molecules (see Figure 1). This
is good evidence for the nested PCR being capable of detec-
ting one molecule of tyrosinase cDNA in the PCR reaction
mix.
With such a sensitive technique, false positives due to
carry-over contamination from previously amplified product
can be a problem. Thirty-one RNA extraction RT-PCR, 12
RT-PCR and 72 PCR negative controls were run. There
were two false positives, both in the RNA extrac-
tion RT-PCR negative control group (discussed below).
The sensitivity of the technique was checked on 3.2 ml
blood samples spiked with melanoma cells. Three melanoma
cell lines were used and four primary uveal melanoma cell
cultures. Blood samples were spiked in two different ways.
An inverting microscope and micropipette and manipulators
were used to transfer single cells. This technique has two
disadvantages. It is not possible to assess the viability of
transferred cells and there is room for marked operator
selection bias (which could work in either direction) in the
choice of the cell transferred, which may not be represen-
tative of the cell suspension. A second technique is to count
viable cells (as assessed by trypan blue exclusion) with a
haemocytometer and then to dilute and transfer an appropri-
ate volume. The problem with this is the difficulty in achiev-
ing even mixing of the cell suspension (cells tend to settle)
and marked inaccuracy at low-level dilutions. Both techni-
ques gave similar answers with a best sensitivity of one cell
per ml of blood (see Table I and Figure 2).
This sensitivity was less than that achieved by extracting
RNA and RT from I04 cells from SK-Mel-23 and from
SK-Mel-19 and diluting the RT mixture, when it proved
possible to detect 0.01 and 0.1 of a cell respectively (consis-
tent with tyrosinase mRNA being a middle abundance
mRNA species with an estimated 100 molecules per cell). The
reduced sensitivity with respect to whole blood is probably
due to saturation of the RT step with 'excess' RNA. No
reduction in the PCR sensitivity was noted when the plasmid-
positive control was spiked into cDNA from negative control
blood.
There were two positive reactions in the first 17 patients
analysed, one from a negative control and alone from the
Figure 1 PCR controls. Lanes 1 and 4 contain > 3.6 copies of
plasmid Pmel34, lanes 2 and 5 contain 1.5 copies and lane 3
contains 0.18 copies. Lanes 4 and 5 contain healthy control blood
cDNA (derived from same sample as lane 13 of Figure 2),
showing no inhibition of PCR sensitivity with whole-blood
cDNA. Lanes 6-8 are negative controls. Lane 9 is the second
round, or nested, PCR positive control and lane 10 is a second-
round negative control. The ladder is the 100 bp ladder (Gibco
BRL, Cat. No. 15628-019).
Fge 2 Results of healthy control 3.2 ml blood samples spiked
with melanoma cells. Lanes 1-3 are spiked with FO-1, lanes 4-6
with FO-2, lanes 7-9 with FO-5, lanes 10-12 with FO-6, lanes
13-15 with SK-Mel-23 and lanes 16-18 are unspiked healthy
control samples. Lanes 1, 4, 7, 10 and 13 were spiked with 100
cells, lanes 2, 5, 8, 11 and 14 were spiked with 10 cells and lanes
3, 6, 9, 12 and 15 were spiked with three cells. The ladder is the
100 bp ladder.
Table I The cells used for spiking blood samples and the best
sensitivity achieved
Name ofcell Best sensitivity
lines Source ofcells achieved
VUP Established cellline denved > IO5cellsml'
from uveal melanoma
SK-mel-19 Established cell line derived 30 cells ml-l
from cutaneous melanoma
SK-mel-23 Established cell line denrved 1 cell ml-'
from cutaneous melanoma
FO-1 Primary uveal melanoma culture 30 cells ml-'
FO-2 Primary uveal melanoma culture 1 cellml-'
FO-5 Primary uveal melanoma culture 1 cell ml-'
FO-6 Primary uveal melanoma culture 30 cells ml-'
patient with the smallest tumour in this series [height 1.9 mm,
largest tumour diameter (LTD) 5.5 mm with no subretinal
fluid or lipofuchsin] which was classified as a suspicious
choroidal naevus. Since both of these occurred early in the
study they were assumed to be false positives and cutaneous
melanocytes were thought to be the most likely source.
Subsequently two blood samples were taken through the
same needle (using the Vacutainer system) and the first sam-
ple discarded. Since then there have been no positives from
71 samples (Fisher's exact P = 0.035, two-tailed).
Results on patients with melanoma
We tested the blood of 36 patients with active uveal
melanoma. Thirty-five were cases of active intraocular uveal
melanoma and one patient was a 66-year-old male who had
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an orbital recurrence 9 years after local resection of an
epithelioid cell uveal melanoma (the recurrence was subse-
quently proven by biopsy). The 35 intraocular uveal
melanoma patients consisd of 18 men and 17 women whose
ages ranged from 23 to 86 years (mean age 64 years) and
whose tumours ranged in height from 2.0 to 15mm (mean
7.7 mm and median 7.2 mm) and the LTD ranged from 7 to
20 mm (mean 13 mm and median 12mm). Twenty-eight of
the tumours were pigmented, five were lightly pigmented and
two were alanotic.
Fifteen patients had second samples taken, and these were
also negative.
The P-actin RT-PCR positive controls gave strong signals
in all cases, thus both RNA preparation and cDNA synthesis
were successful. In addition, amplification of tyrosinase
sequences from plasmid performed on the three dilutions
described above showed that the PCR plication steps
also worked and we conclude that the negative results were
not due to any technical problems.
As we were unable to find circulating melanoma cells in
patients with primary disease, we tested six patients (two men
and four women) with advanced metastatic cutaneous
melanoma (who had not received chemotherapy), and they
too were all negative. RNA extraction yield was checked by
optical density readings (which were satisfactory at 30-60 g
per 3 ml blood sample) and integrity by demonstating 285
and 185 rRNA bands on denaturing RNA ges, in additon
to successful am aon of P-actin cDNA in RT-PCR
reactions.
Results onperioperatve bloodsanples
It has been suggested that surgial procedures can provoke
metastatic spread of ocular melanoma. Perioperative blood
samples were taken from 20 procedures: 11 enucleations, four
insertions of radioactive plaques (brachytherapy), four inser-
tions of tantalum markers (as a prelude for proton beam
radiotherapy) and two trapdoor intraocular biopsies (one
combined with insertion of tantalum markers). The blood
was taken at the end of surgery for all the procedures with
the exception of enucleations, when the blood sample was
taken at the time the optic nerve was cut. All these samples
were also negative; again RNA isolation, cDNA synthesis
and PCR controls gave clear signals.
There were no positive results in 51 samples from 36 patients
with active uveal melanoma and none in six samples from six
patients with advanced metastatic cutaneous melanoma. The
two positive results were in a control patient (with acute
glaucoma) and in a patient with a suspicious choroidal
naevus, and both ofthese have been treated as false positives.
The probable origin of these false positives is contamination
of the samples by cutaneous melanocytes. These two false
positives occurred early in the study and there were no more
postives following a change in protocol for blood smpling.
The resolution of the technique is good and can detect down
to one melanoma cell per ml of blood. This includes two
cases where we cultured cells from the melanoma and showed
that we could detect those cells spiked into blood samples
but not in that patient's blood. These findings are in contrast
to the two previous studies (Smith et al., 1991; Tobal et al.,
1993). In our pilot study (Tobal et al., 1993), it appeared to
be possble to detect two VUP cells per ml of bklo, but we
have been unable to repeat this, and our sensitivity for this
cell line is >10' VUP cellsml-'. Thr is often a short
'honeymoon' period in performing such sensitive PCR while
there is a build-up of product before carry-over contamina-
tion becomes a probkm, arising both from setting up the
PCR and collection and handling of the sample, RNA ext-
raction and RT steps. Carry-over of one moklcule (which
corresponds to 10-'jl of a positive reaction product) is
sufficient for a false-positive reaction. It is probable that this
honeymoon period was shorter than realised and that the
results are expliable by unrecognised carry-over contamina-
tion. Following completion of the pilot study, we had
sigifiant technical problems with false postives which took
12 months to overcome. A similar explanation may apply to
the first study (Smith et al., 1991).
The problem of contamination causing false positives in
PCR-based assays is well recognised (Lo et al., 1989; Sarkar
and Sommer, 1990). The difficulty of genrating negative
controls using RT-PCR led Chelly et al. (1989) to propose
the concept of ilklgitimate transcription, namely that any cell
would produce transcripts from any gene and s d
exploiting this to get supposedly tissue-s transcripts by
using RT-PCR on peripheral blood. The present study is
strong evidenc against ilgitimate transcription for
tyrosinase in peripheral blood.
An explanation for our negative findings would be that we
are looking in the wrong place. Blood from the eye would
have to pass both the pulmonary and a systemic capillary
bed before reaching a peripheral vein. There is evidence,
however, that melanoma cells can successfully traverse capil-
lary beds and that many organs have relatively large
arteriovenous anastomoses of 100-400pm (Prinzmetal et al.,
1948; Tobin and Zariquiey, 1950). Moreover, this objection
should not apply in the cases of the patients with advanced
metastatic cutaneous melanoma.
The positive controls worked well and suggest that there is
kss than one melanoma cell per ml of blood in the circula-
tion of paients with melanoma - even in those with
advanced disease. One cell per ml ofblood would still corres-
pond to a total of 4 500 crculating cells (for a typical blood
volume of 4.5 1). Fifty-seven samples would be expected to
have an occasional positive if more than 45 circulating cells
are present at any one time. Clearly, the sing of only
one cell would be theoretically sufficient for the establishment
of a metastatic deposit and that sheding could be intermit-
tent. The most likely explanation is that there are far fewer
circulating malignant cells than commonly supposed in these
patients. It is probable that any other technique that looks
for single metastatic cells in peripheral blood will prove to be
no more successful.
The failure to find circulating melanoma cells during sur-
gical procedures such as enucleation argues against surgery
as being the cause of subsequent metastatic disease. Uveal
melanomas are relatively slow growing, and it is thought that
it takes several years to reach a size which would necesstate
enucleation (McLean et al., 1980). Iftwo-thirds ofmetastatic
deposits are the result of surgically triggered spread [and
assuming that the tumour has been present for 5 years
(McLean et al., 1980) and that it takes about 20min to
remove an eyel then the re4uired hing rate must be
increased by 10' during the period of the surgery, and this
should have been detectable. Therefore, it is unlikely that
surgery causes any significant increase in melanoma cell shed-
ding. There is other evidence for this. There is no difference
in overall survival between different treatment options
[enucleation vs brachytherapy (Augsburger et al., 1990) vs
proton beam radiotherapy (Seddon et al., 1990) vs local
resection(Foulds et al., 1987]. Further preoperative
radiotherapy (Bornfeld et al., 1989), before enucleation, does
not improve overall survival.
This is the first large series reporting the use of RT-PCR
in the detection ofciculating metastatic cells from melanoma
tumours and, unfortunately, it would appear not to live up
to its initial promise. The technique may be of more use in
detecting metastatic cells in other tumours, paricularly
neuroblastoma (Burchill et al., 1994).
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